Combined Exendin-4 and Rituximab Treatment Improves β-Cell Function and Delays Disease Progression in NOD Mice.

Byetta (exenatide) - AstraZeneca

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42737905

Baicheng Ma; Huan Yang; Jianjun Xiong; Jiashuo Qiu; Jie Zhang; Likun Yu; Shan He; Xingnuan Li; Yongbin Wang

Sep 16, 2026